Valentina Gburcik

Valentina Gburcik

Dr Valentina Gburcik is an analyst at GlobalData covering cardiovascular and metabolic disorders.

Follow Valentina Gburcik: Website |


End of the diabetes blockbuster: We are entering the “me-too” era

End of the diabetes blockbuster: We are entering the “me-too” era

May 30, 2013 7:12 am by | 1 Comments

Takeda announced positive late-stage results for its new type 2 diabetes drug, fasiglifam (TAK-875), the first GPR40 agonist to reach late-stage development. Fasiglifam has the potential to be a compelling…